Value Pharma

Product NDC: 42787-101
11-digit product format: 427870101
Labeler code: 42787
Product ID: 42787-101_7d7783ae-8ad8-57cd-e053-2a91aa0a27e8
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin
Dosage form: TABLET
Route: ORAL
Labeler: Ajes Pharmaceuticals,LLC
Application: part343
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2012-10-01
Marketing end: 0000-00-00
Substance: ASPIRIN
Active strength: 81 mg/81mg
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	42787-101		I	Inactivated by FDA	2026-10-16
excluded product	product	42787-101		I	Inactivated by FDA	2026-10-16
excluded package	package	42787-101	42787-101-50	I	Inactivated by FDA	2026-10-16
excluded package	package	42787-101	42787-101-12	I	Inactivated by FDA	2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 84 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42787-101-12	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42787-101-50	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42787-101-12	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42787-101-50	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42787-101-12	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42787-101-50	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42787-101-12	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42787-101-50	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42787-101-12	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42787-101-50	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42787-101-12	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42787-101-50	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42787-101-12	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42787-101-50	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42787-101-12	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42787-101-50	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42787-101-12	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42787-101-50	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42787-101-12	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42787-101-50	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42787-101-12	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42787-101-50	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42787-101-12	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42787-101-50	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	42787-101-12	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	42787-101-50	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	42787-101-12	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	42787-101-50	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	42787-101-12	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	42787-101-50	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
42787-101-12	2020-01-31	C162847	48780-1	9d75b9d1-1c17-f424-e053-dadaa90a57ce	DRUG FACTS
42787-101-50	2020-01-31	C162847	48780-1	9d75b9d0-151f-f424-e053-dadaa90a57ce	DRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
42787-101-50	Value PharmaAspirin Pain Reliever	4050 mg in 1 BOTTLE	TABLET	4050	4
42787-101-50	Value PharmaAspirin Pain Reliever	1 in 1 CARTON	TABLET	1	4
42787-101-12	Value PharmaAspirin Pain Reliever	1 in 1 CARTON	TABLET	1	2
42787-101-12	Value PharmaAspirin Pain Reliever	81000 mg in 1 BOTTLE	TABLET	81000	2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Aspirin	ACTIVE INGREDIENT	R16CO5Y76E	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
Aspirin	ACTIVE MOIETY	R16CO5Y76E	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
Croscarmellose Sodium	INACTIVE INGREDIENT	M28OL1HH48	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
Silicon Dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
Stearic Acid	INACTIVE INGREDIENT	4ELV7Z65AP	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
talc	INACTIVE INGREDIENT	7SEV7J4R1U	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
Titanium Dioxide	INACTIVE INGREDIENT	15FIX9V2JP	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
Triethyl Citrate	INACTIVE INGREDIENT	8Z96QXD6UM	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	3
Aspirin	ACTIVE INGREDIENT	R16CO5Y76E	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1
Aspirin	ACTIVE MOIETY	R16CO5Y76E	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1
Croscarmellose Sodium	INACTIVE INGREDIENT	M28OL1HH48	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1
Silicon Dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1
Stearic Acid	INACTIVE INGREDIENT	4ELV7Z65AP	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1
talc	INACTIVE INGREDIENT	7SEV7J4R1U	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1
Titanium Dioxide	INACTIVE INGREDIENT	15FIX9V2JP	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1
Triethyl Citrate	INACTIVE INGREDIENT	8Z96QXD6UM	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42787-101	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	4	Legacy NDC, 2 package rows	20181221_76d7e3f0-bff3-4ae4-8e1f-dc2495f3783b.zip
42787-101	VALUE PHARMA ASPIRIN PAIN RELIEVER (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2	Legacy NDC, 2 package rows	20181221_de3e223f-8d22-4034-b049-983b4a60daf5.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	76d7e3f0-bff3-4ae4-8e1f-dc2495f3783b	4
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	76d7e3f0-bff3-4ae4-8e1f-dc2495f3783b	4
308416	ASA 81 MG Delayed Release Oral Tablet	SY	76d7e3f0-bff3-4ae4-8e1f-dc2495f3783b	4
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	76d7e3f0-bff3-4ae4-8e1f-dc2495f3783b	4
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	de3e223f-8d22-4034-b049-983b4a60daf5	2
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	de3e223f-8d22-4034-b049-983b4a60daf5	2
308416	ASA 81 MG Delayed Release Oral Tablet	SY	de3e223f-8d22-4034-b049-983b4a60daf5	2
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	de3e223f-8d22-4034-b049-983b4a60daf5	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
42787-101-12	42787010112	1 in 1 CARTON		Historical
42787-101-50	42787010150	4050 mg in 1 BOTTLE	4050 mg	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DRUG FACTS	Ajes Pharmaceuticals,LLC	2018-12-20	HUMAN OTC DRUG LABEL	4
DRUG FACTS	Ajes Pharmaceuticals,LLC	2018-12-20	HUMAN OTC DRUG LABEL	2